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open access to food and water and a daily orally dosage of 0.15 mg/g
body weight of FORTIGEL or placebo.
The development of osteoarthritis in knee joints was scored 0 - 4 in
haematoxylin stainings. Osteoarthritis was assessed as 0 ¼ no apparent
changes; 1 ¼ loss of superﬁcial zone; 2 ¼ defects limited above tide-
mark; 3 ¼ defects extending to calciﬁed cartilage and 4 ¼ exposure of
subchondral bone.
Additionally to histochemical classiﬁcation the plasma adiponectin
levels in the STR/ort mice were tested over the time of experimentation.
A possible correlation between grade of osteoarthritis and different
osteoarthritic risk factors like obesity, aging and moreover, of adipo-
nectin plasma level were assessed.
Analysis of variance was performed using the Kruskal-Wallis test. For
comparison of collagen hydrolysate and placebo treated animal cohorts
the Mann-Whitney U-test was used. Correlations of osteoarthritic
changes, weight gain and adiponectin plasma level were analyzed
according to Pearson. P values < 0.05 were considered to be signiﬁcant.
Results: In 12 weeks old non-treated STR/ort mice no osteoarthritic
changes of the cartilage or slightly defects of the superﬁcial zone were
observed (Fig. 1 a, b). With age grade of osteoarthritis increased
signiﬁcantly and cartilage destructions above the joint tidemark with
partially exposed subchondral bone was seen.
In addition to degenerative cartilage changes with age male STR/ort
mice become signiﬁcantly obese. Mean body weight of STR/ort mice
increased over the experimental period of six month from 36 to 49 g
(Fig. 2).
Over this time an increased age-related adiponectin plasma level was
determined (Fig. 3).
Out of our ﬁndings we computed a signiﬁcant correlation of an
increased plasma adiponectin level and potentiated grade of osteoar-
thritis in untreated animals. Moreover, body weight gain and an
increased grade of osteoarthritis were also signiﬁcantly correlated (Fig.
4 a). No correlation was seen between adiponectin amount and body
weight in the mouse model (Fig. 4 b).
The determined grade of osteoarthritis decreased signiﬁcantly by
FORTIGEL administration in comparison to the placebo treated animals
(Fig. 5). Moreover, FORTIGEL treatment seems to improve osteoarthritis
related immobility of the animals reﬂected by a less body weight gain
(Fig. 6). The fact that FORTIGEL diminishes osteoarthritis will be
conﬁrmed by a lower adiponectin level in the plasma of these animals
(Fig. 7).
Conclusions: Osteoarthritic changes are well correlated with body
weight and adiponectin plasma level. In contrast, no correlation was
found between adiponectin amount and body weight gain.
A low adiponectin level and reduced body weight, after FORTIGEL
treatment suggested that FORTIGEL could be a potential disease
modifying agent for the treatment of degenerative joint diseases.
Our animal study demonstrates that incidence of severe joint destruc-
tionwas clearly reduced after FORTIGEL treatment and that adiponectin
is a suitable indication biomarker for osteoarthritis.140
PROGNOSTIC RELEVANCE OF IN VIVO T2-MAPPING OF MACT IN
KNEE JOINTS ON THE CLINICAL LONGTIME OUTCOME
G.M. Hobusch, M. Brix, C. Chiari, L. Negrin, R. Windhager, S. Trattnig,
S. Domayer. Med. Univ. of Vienna, Vienna, Austria
Purpose: In physically active people injuries oft the joint cartilage are
common and cause pain and loss of joint function. There is no potential
of self-repair in joint cartilage, but without any therapy cartilage defects
may lead to an early onset of osteoarthritis and patients will need a total
joint arthroplasty. Matrix-associated autologous chondrocyte trans-
plantation (MACT) is used to treat cartilage defects. However MACT is
a surgically demanding two-step procedure, currently using different
cellseeded biomatrices made of collagen, hyaluronan and/or ﬁbrin. By
now clinical follow up data of patients who underwent MACT show
improvements in clinical outcome when using hyaluronan 3D-scafolds
or ﬁbrin-hyaluronan scaffolds until ten years. MRI techniques have been
assessed to describe cartilage defects and repair tissue with standard
imaging and and have shown correlations between cartilage and clin-
ical outcome. T2 mapping provides information about collagen
concentration and network and has shown a signiﬁcant correlation of
T2 values of Repair tissue with clinical outcome of patients after one
year postoperatively in patients who received microfracturingtechnique. No prognostic long-term data is known about T2 values. The
aim of this study was to evaluate T2 mapping concerning its prognostic
potential to predict long-term clinical outcome in patients who were
treated by MACT in the knee joint.
Methods:We assessed the clinical long-term outcome of 16 patients (11
male/ 5 female) with a mean age at surgery of 32 years (range 18 - 51
years), who had been treated with MACT in the knee joint at the
department of orthopaedic surgery and the department of traumatol-
ogy at the Medical University of Vienna from 2001 until 2005. 11
patients had received a scaffold containing hyaluronan (Hyalocraft C)
after cartilage defect sizes of 4,4 1,9cm2. 5 patients have been treated
because of defects with 1,8 - 4,9cm2 with ﬁbrin and hyaluronan scaffold
(Prochon). The mean follow-up time after surgery was 100 months (SD
20; range 79-134 months; median 96 months). 2 patients were lost of
Follow up (12,5%), one patient had received total knee arthroplasty.
Thirteen patients were available for clinical long-term follow-up
examinations done by two different observers including the Lysholm
score, subjective and objective IKDC of all patients. Magnetic resonance
(MR) examinations were performed on a 3 T MR unit one year after
surgery at least. T2 relaxation times were obtained with a multi-echo
spin-echo technique. T2 maps were obtained using a pixel wise, mon-
oexponential non-negative least squares ﬁt analysis. Slices covering the
cartilage RT were selected and region of interest analysis was done. An
individual T2 index was calculated with global mean T2 of the RT and
the global mean T2 of normal, hyaline cartilage. Bivariate correlation
analysis and a paired, two tailed t test were used for statistics.
Results: The mean T2 index was 98,9 (range: 65-116). The mean
Lysholm score at the latest time of follow-up was 81 points (range 43-
100) differed from the Lysholm score from 1 year postoperative (mean
91points; range 76-100). The subjective IKDC at latest time of follow-up
was 63 points (range: 24-100). The correlation of the T2 index and long-
term Lysholm score was signiﬁcant (p<0,032*, rs¼ 0,618). The corre-
lation of the Lysholm score 1year postoperative (p<0,235, rs¼0,340)
and of the long-term subjective IKDC with the (p<0,307, rs¼0,322) T2
index were not signiﬁcant.
Conclusions: Patients treated by MACT in the knee show good clinical
long-term results. The T2 index of patients one year postoperatively
serves as a signiﬁcant prognostic long-term factor for the clinical
outcome of patients treated by MACT in the knee. This data has to be
validated by a higher number of patients.141
DYNAMIC ANALYSIS OF CYTOKINE EXPRESSION IN SYNOVIAL FLUID
AFTER ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION SURGERY
M. Inoue, K. Tsuji, I. Sekiya, T. Muneta. Tokyo Med. and Dental Univ.,
Tokyo, Japan
Purpose: Synovial ﬂuid is an interstitial ﬂuid secreted by ﬁbroblast-like
cells in the synovial membrane. It is a highly viscous liquid containing
hyaluronic acid and various cytokines. The physiological functions of
synovial ﬂuid include reduction of friction, shock absorption, nutrient,
and waste transportation in the joint. In addition, previous reports
showed that mesenchymal stem cell-like cells, those are considered to
contribute the tissue regeneration, reside in synovial ﬂuid and the
number of these cells increased after joint injury. These data strongly
suggest that condition of synovial ﬂuid may greatly inﬂuence joint
homeostasis. This study aims the dynamic analysis of cytokine levels in
synovial ﬂuid after anterior cruciate ligament reconstruction surgery
(ACL-R). Since ACL-R patients are regarded as a high-risk osteoarthritis
(OA) group as it was reported that more than 30% of ACL-R patients
develop radiographic OA on an average of 7.8 years after surgery, with
most patients having no evidence of OA at the time of ACL-R, we expect
that this study will give us critical information to identify prognostic
factors for joint degeneration after injury.
Methods: This study was approved by the Ethics Committee of this
institute. All patients included in this study gave their full, written,
informed consent for participation prior to the operative procedure.
Synovial ﬂuid was obtained from the patients who underwent ACL-R
from January till August 2012 in our university hospital (Just before
surgery, at day 3, at 3 weeks, and at 5 weeks post surgery: 26 samples,
female: 13 male: 13, 14-62 year-old, average 30 year-old). Cytokine
levels in synovial ﬂuid were measured by ELISA (R and D systems, MN).
In this report, we examined TNF-alpha and IL1-beta as pro-inﬂamma-
tory cytokines and BMP7 as an anti-inﬂammatory and anti-catabolic
factor for articular cartilage. Pearson's correlation coefﬁcient test,
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for the statistical analysis and values of p < 0.05 were considered
signiﬁcant.
Results: Before ACL-R, average volume of synovial ﬂuid was 7.6+/-7.2ml
although it varied from individual patient (Max 15.5ml, Min 0.5ml). In
all patients, synovial ﬂuid volume surged around 3-fold at day 3 post
surgery (average 21.6+/-8.0ml, Max 25ml, Min 7.8ml). In most patients,
synovial ﬂuid volume returned to the basal level within 3 weeks post
surgery. Concentrations of TNF-alpha and IL1-beta were signiﬁcantly
increased at day 3 post surgery if compared to those at pre-operation
(p<0.05). In addition, the concentration of TNF-alpha was positively
correlated with the volume of synovial ﬂuid at pre-operation (r¼0.995,
p<0.01) and day3 post-operation (r¼0.535, p<0.05) while IL1-beta
levels were not at any time point. Throughout the time point, BMP7
levels were very low and did not change signiﬁcantly at pre- and post-
operation. Surprisingly, BMP7 levels were positively correlated with
IL1-beta levels at day 3 post-operation (r¼0.59, p<0.01). These suggest
that BMP7 may have subtle anti-inﬂammatory/anti-catabolic effect on
cartilage at the acute inﬂammatory stage after joint injury.
Conclusion: This is a longitudinal study of dynamic analysis of cytokine
levels in synovial ﬂuid from each patient undergoing ACL-R. In this
report, we examined the levels of TNF-alpha, IL1-beta, and BMP7 in
synovial ﬂuid and observed that TNF-alpha levels were signiﬁcantly
correlated with the volume of synovial ﬂuid.Figure 2. Method to determine initial concentration of biomarker within the syno-
vial ﬂuid.142
BIOMARKERS TO IDENTIFY CARTILAGE DAMAGE ARE INCREASED
AFTER A JOINT BLEED; AN EXPLORATIVE HUMAN AND CANINE IN
VIVO STUDY
L.F. van Vulpen, M.E. van Meegeren, G. Roosendaal, S.C. Mastbergen, F.P.
Lafeber. UMC Utrecht, Utrecht, The Netherlands
Purpose: Biomarkers have the capacity to detect cartilage degradation
in degenerative joint diseases such as osteoarthritis. They have the
potential to detect early, pre-radiographic changes in joints. In hae-
mophilia, a disease accompanied with arthropathy due to spontaneous
bleedings in the joint, a panel of four biomarkers for cartilage degra-
dation is associated with overall radiographic joint damage (Jansen et
al., A&R 2009). In the present study, we investigated for the ﬁrst time
whether these biochemical markers can detect cartilage degradation
immediately after a joint bleed.
Methods: Urinary C-terminal telopeptide of type II collagen (CTX-II),
serum Cartilage Oligmeric Matrix Protein (COMP), serum C1,2C
(cleavage product of both collagen type I and type II), and serum CS846
(the 864 epitope of aggrecan chondroitin sulphate) were measured in
samples of patients with haemophilia (n¼8). Samples were collected at
three different time points: within 2 days, after 3-5 days, and about 90
days after the patient reported a joint bleed (the last time point
considered baseline). In parallel, the same biomarkers were measured
in an experimental joint bleeding model using 7 dogs at four different
time points: before they received an experimental joint bleed (induced
by intra-articular autologous blood injections over 5 days), immediately
after this bleeding episode, 5 and 90 days later.
Results: In haemophilia patients, the levels of all four biomarkers were
elevated 3-5 days after a joint bleed when compared to baseline levels,
although the increase was not statistically signiﬁcant for each of the
biomarkers individual. A combined score of the four biomarkers 3-5
days after the bleed showed a statistically signiﬁcant increase when
compared to levels directly after the bleed (ratio of 1.010.17 at day 1-2
to a ratio of 1.100.20 at day 5; p¼0.024).
In parallel, in dogs, 5 days after the experimentally induced joint bleed,
the same panel of biomarkers (except sCOMP) was increased; uCTX-II
and the combined biomarker score being statistically signiﬁcantly
different from the time point directly after the bleed (3.810.85 vs
2.601.41, p¼0.007 and a ratio of 1.170.42 compared to a ratio of
0.980.39; p¼0.02 respectively). After 90 days the levels were similar
to the pre-bleeding levels.
Conclusions: This study demonstrates that biochemical markers of
joint tissue damage increase after a single joint bleed, both in haemo-
philia patients and after an experimentally induced canine joint bleed.
Due to the great variation in patients and bleeding characteristics in
a small number of patients, these effects were only approaching
statistical signiﬁcance. A combined score could be used to detect
cartilage degradation immediately after a joint bleed.Irrespectively, this explorative study clearly warrants further research
on the value of biochemical markers to detect the destructive properties
of a joint bleed.
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MAGNETICCOLLECTIONOFJOINT-LEVELOSTEOARTHRITISBIOMARKERS
E.G. Yarmola, Z.A. Kaufman, D.P. Arnold, J.P. Dobson, K.D. Allen. Univ. of
Florida, Gainesville, FL, USA
Purpose: Osteoarthritis (OA) comprises a continuum of joint remod-
eling across several years. The initiating events of OA are often
unknown, and OA is not typically diagnosed until signiﬁcant joint
degeneration has occurred. Detection of early-stage OA may provide
a better therapeutic window for disease modifying OA drugs, and the
OA research community has placed an emphasis on the development of
molecular OA biomarkers with the potential to detect OA prior to
radiographic evidence of joint destruction. The purpose of this study is
to describe a new magnetic nanoparticle-based technology for the
extraction of molecular biomarkers from an OA-affected joint (Figure 1).
Methods: In the magnetic collection technique, magnetic particles
functionalized with an antibody to a speciﬁc OA biomarker are injected
into the joint. Following an incubation period, a magnetic micro-needle
is inserted into the joint space, collecting a portion of the particle-
biomarker conjugates. Finally, the probe is removed, and biomarkers
and particles are processed for analysis. To determine the concentration
of biomarker within the joint, the amount of antibody and biomarker
collected with the magnetic needle must be quantiﬁed. As long as the
antibody-conjugated particles do not signiﬁcantly deplete the
biomarker within a joint, the law of mass action can be applied to
determine the joint-level biomarker concentration (Figure 2).
As a proof of concept, antibodies to the collagen degradation product
CTX-II were conjugated to horseradish peroxidase (HRP) and covalently
attached to 1 mm magnetic particles using an EDC crosslinking agent.
These particles were mixed with bovine synovial ﬂuid and allowed to
bind CTX-II for 5min. After incubation, particles were collected from the
synovial ﬂuid using an NdFeB micro-needle. The remaining ﬂuid and
uncollected particles were separated using a magnetic plate. Harvested
particles were diluted in 35 mL PBS containing 0.05% TWEEN-20, 2% BSA,
and 2 mM EDTA. 1 mL of sample were used for HRP analysis, with the
remaining 34 mL of sample heated at 85C for 3 min to release CTX-II.
Control experiments demonstrated brief heating completely disrupts
the interaction of biomarker and antibody, but did not signiﬁcantly
affect the level of detectable biomarker (not shown). Samples were
cooled to room temperature and centrifuged at 18,000g for 10 min.
Supernatants were analyzed for CTXII using Serum Pre-Clinical Carti-
Laps ELISA kit.
